Evidence map›Paper›PMID 18795317›Full record

ArticleInternational archives of occupational and environmental health2009

Sickness absence and return to work rates in women with breast cancer.

Corné A M Roelen, Petra C Koopmans, Jan H de Graaf, Fulya Balak, Johan W Groothoff

Abstract read
PubMed Publisher
In one paragraph

Article in International archives of occupational and environmental health, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Prognostic factors for return to work in breast cancer survivors.The Cochrane database of systematic reviews · 2025
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Return to work and psychosocial trajectories after breast cancer: a longitudinal and sequential approach.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  6. Article
  7. Informing the development of multidisciplinary interventions to help breast cancer patients return to work: a qualitative study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Article
  8. Financial difficulties in breast cancer survivors with and without migration background in Germany-results from the prospective multicentre cohort study BRENDA II.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Quality of working life of cancer survivors: development of a cancer-specific questionnaire.Journal of cancer survivorship : research and practice · 2016
    Article
  15. Article
  16. Article
  17. Article
  18. Return to work after treatment for primary breast cancer over a 6-year period: results from a prospective study comparing patients with the general population.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2013
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Corné A M RoelenDepartment of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. corne.roelen@arboned.nl
Petra C Koopmans
Jan H de Graaf
Fulya Balak
Johan W Groothoff

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeMost women are diagnosed with breast cancer when they are of working age. How long are breast cancer patients absent? How many of them return to work?

methodsArboNed Occupational Health Services documents sickness absence data of 1 million workers of whom 40% were women. Between 2001 and 2005, 2,259 women had 2,361 episodes of sickness absence due to breast cancer. These absence episodes were followed for 2 years using Kaplan-Meier analysis.

resultsThe mean +/- standard error of mean duration of absence due to breast cancer was 349 +/- 5 days. Thirty-seven percent of absences lasted longer than one year and 12% of absences lasted longer than 2 years particularly in women aged 25-34 years.

conclusionsThe mean duration of sickness absence due to breast cancer was nearly a year, but most women returned to work. The results of the study can be used as a reference for return to work of women following breast cancer.

Indexed as

AbsenteeismConvalescenceAdultAgedBreast NeoplasmsFemaleHumansMiddle AgedNetherlandsOccupational Health ServicesRegistriesSick LeaveSurvival AnalysisTime FactorsYoung Adult

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.